Our colleagues at MAP Patient Access are running a webinar: Navigating EU HTA – the future of supranational HTA initiatives; lessons learnt so far… Sven and Maud will be joining an expert panel made up of HTA and industry experts, as they provide an update on EU HTA and look at initiatives such as Beneluxa to understand lessons that can be applied to successfully navigate EU JCAs.
Alongside Sven and Maud, the expert panel includes:
– Andrew Olaye, General Manager, UK and Ireland and Head of EMEA Market Access at Orchard Therapeutics
– Meindert Boysen PharmD MSc, Independent HTA Expert
– Nisha Tailor, Head of Policy & Public Affairs at MAP Patient Access (Chair)
By attending this webinar, you will:
– Get an update on the EU HTA Implementation Act and progress towards the 2025 start
– Hear different views, experiences and learnings from an HTA expert and industry perspective via a panel discussion
